3053
NOVOe001-A
General
Cell Line |
|
| hPSCreg name | NOVOe001-A |
| Cite as: | NOVOe001-A (RRID:CVCL_B4K7) |
| Alternative name(s) |
3053
|
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines | No similar lines found. |
| Last update | 22nd June 2021 |
| User feedback | |
Provider |
|
| Generator |
Novo Nordisk A/S (NOVO)
Contact:
Novo Nordisk A/S (NOVO) |
| Owner | Novo Nordisk A/S (NOVO) |
| Derivation country | Sweden |
External Databases |
|
| BioSamples | SAMEA9232316 |
| Cellosaurus | CVCL_B4K7 |
| Wikidata | Q110433108 |
General Information |
|
| Publications | |
| Projects | |
| * Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
External Databases (Donor) |
|
| BioSamples | SAMEA9232317 |
Ethics
| Was the embryo established purely for research purposes? | No |
| Have both parents consented to the use of the embryo for ESC derivation? | Yes |
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
| If you do not hold the Donor Consent Form, do you know who does? | No |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
| How may genetic information associated with the cell line be accessed? | No information |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | Ethical Committee Gothenburg |
| Approval number | 411-14 |
hESC Derivation
| Date of derivation | 2014-10-10 |
| Supernumerary embryos from IVF treatment? |
Yes
|
| PGD Embryo? |
No |
Culture Conditions
Characterisation
Analysis of Undifferentiated Cells
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46, XX. Chromosome analysis of the fixed cell suspension from this stem cell line has shown an apparently normal female karyotype in 20 cells examined. The preparations obtained from this sample were of sufficient quality to detect numerical and large structural abnormalities.
Passage number: 12
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.